IDiyas

For the Inventor, By the Inventor

Wellesley, MA, United States of America

Rakesh K Jain

USPTO Granted Patents = 34 

 

Average Co-Inventor Count = 4.3

ph-index = 7

Forward Citations = 200(Granted Patents)


Location History:

  • Gilroy, CA (US) (1995 - 1997)
  • Boston, MA (US) (1995 - 2004)
  • Danville, CA (US) (2014 - 2019)
  • Freemont, CA (US) (2020)
  • Wellesley, MA (US) (2015 - 2022)
  • Fremont, CA (US) (2004 - 2024)

Company Filing History:

goldMedal14 out of 2,882 
 
The General Hospital Corporation
 patents
silverMedal7 out of 39 
 
Ardelyx, Inc.
 patents
bronzeMedal5 out of 11 
 
Novabay Pharmaceuticals, Inc.
 patents
4. 4 out of 3,923 
 
Novartis Ag
 patents
5. 3 out of 23 
 
Vicuron Pharmaceuticals Inc.
 patents
6. 3 out of 8,369 
 
Massachusetts Institute of Technology
 patents
7. 1 out of 1,603 
 
Sandoz Gmbh
 patents
8. 1 out of 1 
 
Xtuit Pharmaceuticals, Inc.
 patent
9. 1 out of 4,455 
 
Pfizer Corporation
 patents
10. 1 out of 1 
 
Vicuron Holdings LLC
 patent
where one patent can have more than one assignee

Years Active: 1995-2025

Loading Chart...
Loading Chart...
34 patents (USPTO):
1. 12209088 - Hormone receptor modulators for treating metabolic conditions and disorders (2025-01-28),
2. 12084472 - Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists (2024-09-10),
3. 11718619 - Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators (2023-08-08),
4. 11433136 - Polyacetal polymers, conjugates, particles and uses thereof (2022-09-06),
5. 11427543 - Compounds for targeting cancer stem cells (2022-08-30),
6. 11351144 - Compounds for inhibiting secretory leukocyte protease inhibitor (SLPI) (2022-06-07),
7. 11279765 - Compositions and methods to improve anti-angiogenic therapy and immunotherapy (2022-03-22),
8. 11259714 - System and method for measuring solid stress in tissues (2022-03-01),
9. 11091482 - Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activators (2021-08-17),
10. 10968246 - Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists (2021-04-06),
11. 10793568 - Hormone receptor modulators for treating metabolic conditions and disorders (2020-10-06),
12. 10689459 - Treatment of breast cancer brain metastases (2020-06-23),
13. 10392413 - Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists (2019-08-27),
14. 9919059 - Multistage nanoparticle drug delivery system for the treatment of solid tumors (2018-03-20),
15. 9248117 - Substituted N,N-dihaloamines as antimicrobials (2016-02-02),

Title: The Innovative Mind of Rakesh K Jain

Introduction: Rakesh K Jain, a distinguished inventor based in Wellesley, MA (US), is renowned for his groundbreaking contributions to the field of medical innovations.

Latest Patents: Rakesh K Jain holds several patents related to advanced drug delivery systems and targeted cancer therapies, revolutionizing the way medical treatments are administered.

Career Highlights: With a career spanning several decades, Rakesh K Jain has held prominent positions in leading research institutions and universities, where he has spearheaded numerous projects that have significantly impacted the medical industry.

Collaborations: Throughout his career, Rakesh K Jain has collaborated with top pharmaceutical companies, renowned scientists, and medical professionals to further his research and bring his innovative ideas to life.

Conclusion: Rakesh K Jain's relentless pursuit of innovation and his dedication to improving medical treatments have solidified his position as a pioneering inventor in the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…